Navigation Links
GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older
Date:7/8/2011

as 3.3 million adolescents and adults in the U.S. each year.

About Whooping Cough (Pertussis)  

Pertussis, also known as whooping cough, is a highly contagious respiratory disease characterized by severe coughing fits.  Whooping cough starts off like the common cold and can turn into a persistent cough over time.

About BOOSTRIX

BOOSTRIX is now approved for use as a single dose for active booster immunization against tetanus, diphtheria and pertussis (whooping cough) in individuals 10 years of age and older.  In the U.S., BOOSTRIX was first approved for individuals aged 10-18 in May 2005.  In December 2008, the vaccine was approved for use in adults 19-64 in the U.S.  Since May 2005, more than 20 million doses of BOOSTRIX have been distributed in the U.S. to help protect adolescents and adults from whooping cough, as well as tetanus and diphtheria.

Important Safety Information for BOOSTRIX

  • In clinical studies, common adverse events were injection-site reactions (pain, redness, swelling, and increase in arm circumference), headache, fatigue, and gastrointestinal symptoms
  • Severe allergic reaction after a previous dose of any tetanus toxoid-, diphtheria toxoid-, or pertussis antigen-containing vaccine, or to any component of BOOSTRIX, or encephalopathy within 7 days of a previous pertussis antigen-containing vaccine is a contraindication
  • BOOSTRIX is available in vials and 2 types of prefilled syringes. One type of prefilled syringe has a tip cap which may contain natural rubber latex and a plunger which does not contain latex. The other type has a tip cap and a rubber plunger which contain dry natural latex rubber. Use of these syringes may cause allergic reactions in latex sensitive individuals. The vial stopper does not contain latex
  • The decision to give BOOSTRIX should be based on benefits and risks if Guillain-Barre syn
    '/>"/>

SOURCE Synaptic Digital; GlaxoSmithKline
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
2. GlaxoSmithKline Confirms allis Safety Profile
3. Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint
4. GlaxoSmithKline Wins Environmental Stewardship Award
5. GlaxoSmithKline 15th Annual IMPACT Awards Seek Philadelphia Area and Camden Healthcare Nonprofits
6. GlaxoSmithKline Applauds North Carolinas Child Advocates
7. A Statement from GlaxoSmithKline Consumer Healthcare on FDA Regulation of Smokeless Tobacco Products
8. Mylan Granted Temporary Restraining Order Against GlaxoSmithKline and Apotex Prohibiting the Supply, Sale and/or Importing of a Generic Version of Paxil CR
9. GlaxoSmithKline CEO Interviewed On Half-Year and Q2 Results
10. GlaxoSmithKline Statement in Response to FDA Advisory Committees Vote on Safety of Avandia® (rosiglitazone)
11. ImaginAb, Inc. and GlaxoSmithKline Establish Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Pa. , July 29, 2015 ... UNS), a developer, manufacturer and supplier of injectable ... the Imperium™ platform of instant patch pumps for ... disposable, multi-day wearable insulin pump that does not ... it is prefilled and pre-assembled like an insulin ...
(Date:7/29/2015)... , July 29, 2015 Varian Medical Systems, ... through one of its European subsidiaries, agreed to acquire ... of components and subsystems for X-ray imaging equipment manufacturers. Varian,s ... pay approximately €50 million in cash for Claymount. The ... Claymount is one of the world,s leading ...
(Date:7/29/2015)... July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: NBIX ... 30, 2015. For the second quarter of 2015, the Company reported ... compared to a net loss of $13.4 million, or $0.18 loss ... months ended June 30, 2015, the Company reported a net loss ... net loss of $25.2 million, or $0.35 loss per share, for ...
Breaking Medicine Technology:Unilife Introduces World's First Instant Patch Pump for Insulin 2Unilife Introduces World's First Instant Patch Pump for Insulin 3Unilife Introduces World's First Instant Patch Pump for Insulin 4Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 2Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 3Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 4Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9
... May 11, 2011 As one of the first ... Swedish is home to the fastest growing, most comprehensive ... established the multidisciplinary, robotic-assisted surgical program in 2005 and ... more than any other program in the region. ...
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ... care and gastroenterology markets, today announced that it will ... Specialty Pharmaceuticals Conference in London on Wednesday, May 25, ... will be simultaneously webcast and can be accessed by ...
Cached Medicine Technology:Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 2Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 3Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 4Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 5Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 6Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 7
(Date:7/29/2015)... ... ... According to The Spirits Business on July 16th, a new study ... perpetuating alcohol use disorders. Humans have the same gene, which is called Rsu1. The ... and has given researchers inklings to explore Rsu1 in humans to abate alcohol addiction ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... anticipating testing regulations imposed by the FDA for nicotine laced liquid products. Their ... electronic cigarettes have raised considerably. E-Cigarettes are particularly troublesome to addiction professionals as ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... Michigan, changed its name in July to Kalamazoo Strength & Conditioning. , The ... , and “reflects the evolution of our training center over the past three ...
(Date:7/29/2015)... , ... July 29, 2015 , ... San Fernando ... on Ultherapy. For a limited time only, patients can get the complete treatment process ... for patients who prefer a non-invasive treatment and have loose or sagging skin. ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... For the ... to be featured in the list of the 50 fastest growing companies in Jacksonville. ... around the business community. On July 16th, a team of Vast Bridges staffers were ...
Breaking Medicine News(10 mins):Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:Vast Bridges Continues Its Swift Growth 2
... doctor and five Bulgarian nurses who have been accused of ... capital, Tripoli. ,Three parents appeared on Tuesday with ... .They identified the five Bulgarian women as the nurses who ... in a Benghazi hospital in 1998. ,In 1999, ...
... According to a research conducted by Stephanie Chiuve it was ... heart ailments//. ,U.S. researchers stated that patients suffering ... their lifestyle. ,It was discussed that middle aged ... maintain a proper diet and change their drinking and smoking ...
... estimated obesity-related risk factors have indicated that more the ... health risks// like hypertension, diabetes and hypercholesterolemia. ... in predisposing women to major health risks – researchers ... and treatment are typically based on body mass index ...
... a study published in the Journal of the National ... suffer from premature menopause//. ,Ovarian irradiation and ... most common risk factors associated with early menopausal symptoms. ... with cancer will survive long-term. Survivors have an increased ...
... offer protection against the late, or adult onset of diabetes//. ... by the University of Minnesota has explained that they have ... apparent effect, but they said, that it could be possible ... rich amounts in the coffee bean may be effecting favourably ...
... that the number of sexually transmitted infections is on a ... there was a 3 percent rise in the diagnosis of ... was reported in syphilis cases at 23 percent, but Chlamydia, ... of gonorrhea fell by 13 percent. The highest increase again ...
Cached Medicine News:Health News:Obese Women are more likely to suffer from Major Health Risks 2Health News:Obese Women are more likely to suffer from Major Health Risks 3Health News:Decaffeinated Coffee Might Protect Against Adult Onset Of Diabetes 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... The Auto Suture™ ENDO ... of five (5) atraumatic ... in a variety of ... colorectal and other endoscopic ...
The Auto Suture&trade ENDO RETRACT&trade Maxi instrument has application in a variety of general, thoracic, gynecologic, urologic, and endoscopic procedures for temporary retracting of tissue and sma...
... Products are kept in ... are offered as 1-piece ... or extra long lengths. ... insulation, flush ports, rotating ...
Medicine Products: